Development and external validation of a prediction model for the transition from mild to moderate or severe form of COVID-19 - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Radiology Année : 2023

Development and external validation of a prediction model for the transition from mild to moderate or severe form of COVID-19

Julien Asselineau
  • Fonction : Auteur
Eric Frison
  • Fonction : Auteur
Rkia Achkir
  • Fonction : Auteur
Sophie Regueme
  • Fonction : Auteur
Emilie Klein
  • Fonction : Auteur

Résumé

Objectives COVID-19 pandemic seems to be under control. However, despite the vaccines, 5 to 10% of the patients with mild disease develop moderate to critical forms with potential lethal evolution. In addition to assess lung infection spread, chest CT helps to detect complications. Developing a prediction model to identify at-risk patients of worsening from mild COVID-19 combining simple clinical and biological parameters with qualitative or quantitative data using CT would be relevant to organizing optimal patient management.Methods Four French hospitals were used for model training and internal validation. External validation was conducted in two independent hospitals. We used easy-to-obtain clinical (age, gender, smoking, symptoms’ onset, cardiovascular comorbidities, diabetes, chronic respiratory diseases, immunosuppression) and biological parameters (lymphocytes, CRP) with qualitative or quantitative data (including radiomics) from the initial CT in mild COVID-19 patients.Results Qualitative CT scan with clinical and biological parameters can predict which patients with an initial mild presentation would develop a moderate to critical form of COVID-19, with a c-index of 0.70 (95% CI 0.63; 0.77). CT scan quantification improved the performance of the prediction up to 0.73 (95% CI 0.67; 0.79) and radiomics up to 0.77 (95% CI 0.71; 0.83). Results were similar in both validation cohorts, considering CT scans with or without injection.Conclusion Adding CT scan quantification or radiomics to simple clinical and biological parameters can better predict which patients with an initial mild COVID-19 would worsen than qualitative analyses alone. This tool could help to the fair use of healthcare resources and to screen patients for potential new drugs to prevent a pejorative evolution of COVID-19.Clinical Trial Registration NCT04481620. Clinical relevance statement CT scan quantification or radiomics analysis is superior to qualitative analysis, when used with simple clinical and biological parameters, to determine which patients with an initial mild presentation of COVID-19 would worsen to a moderate to critical form.
Fichier principal
Vignette du fichier
2023 Zysman et al., Development.pdf (909.83 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04153209 , version 1 (06-07-2023)

Identifiants

Citer

Maéva Zysman, Julien Asselineau, Olivier Saut, Eric Frison, Mathilde Oranger, et al.. Development and external validation of a prediction model for the transition from mild to moderate or severe form of COVID-19. European Radiology, 2023, 33, pp.9262-9274. ⟨10.1007/s00330-023-09759-x⟩. ⟨hal-04153209⟩
63 Consultations
32 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More